Cognitive and Neuroprotective · 2020

AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism

Peptídeo AEDG (Epithalon) estimula a expressão gênica e a síntese proteica durante a neurogênese: possível mecanismo epigenético

Khavinson VKh, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B

Molecules

DOI: 10.3390/molecules25030609 PubMed: 32019204

Summary

This study investigated the influence of the AEDG peptide (Epithalon) on neurogenic differentiation and protein synthesis in human gingival mesenchymal stem cells (hGMSCs). The cells were treated with the tetrapeptide and analyzed by quantitative RT-PCR, Western blot, and confocal microscopy to evaluate the expression of specific neurogenic markers including Nestin, GAP43, beta-Tubulin III, and Doublecortin.

The results demonstrated that AEDG significantly increased the expression of all neurogenic differentiation markers evaluated, with an increase of 1.6 to 1.8 fold at the mRNA level compared to controls. Molecular modeling revealed that the AEDG peptide preferentially binds to histones H1/6 and H1/3 at specific sites that interact with DNA, suggesting an epigenetic mechanism for the observed neurogenic effects.

Published in the journal Molecules, this study was pioneering in proposing a concrete epigenetic mechanism for Epithalon's action: direct interaction with linker histones, which modulates chromatin compaction and consequently the accessibility of genes involved in neurogenesis. These findings are directly relevant to N-Acetyl Epithalon, since N-acetylation does not alter the histone-binding properties of the core AEDG sequence, but only improves the stability and bioavailability of the peptide.

Related Peptide

N-Acetyl Epithalon

N-Acetyl Epitalon, N-Acetyl Epithalone, Ac-AEDG, N-Acetyl Epithalon Amidate

Modified version of Epithalon with N-acetylation that confers greater enzymatic stability and bioavailability. Retains the same mechanisms of action as the original Epithalon (telomerase activation, pineal gland support) with extended half-life and potential for oral administration.